Abstract This paper outlines the recommendations from the Association of Colon & Rectal Surgeons of India (ACRSI) practice guidelines for the management of haemorrhoids-2016. It includes diagnosis and management of haemorrhoids including dietary, non-surgical, and surgical techniques. These guidelines are intended for the use of general practitioners, general surgeons, colorectal surgeons, and gastrointestinal surgeons in India.
Introduction and Methodology
Haemorrhoidal disease is one of the most common anorectal conditions encountered in daily practice by general practitioners, general surgeons, and gastrointestinal surgeons in India. It has been projected that about 50% of the population would have haemorrhoids at some point in their life probably by the time they reach the age 50, and approximately 5% population suffer from haemorrhoids at any given point of time [1, 2] . Taking into account the devastating nature of the disease and high prevalence in India, the evidence-based practice appears essential in the management of haemorrhoids. Present practice parameters aim at developing evidence-based recommendations for the management of haemorrhoids in Indian perspectives.
This practice guideline for the management of haemorrhoids, framed by the Association of Colon & Rectal Surgeons of India (ACRSI) has been developed by experts from across the country with immense experience in managing patients with haemorrhoids. Each section was reviewed by an individual expert in the committee, which was later presented and discussed; and a consensus statement was arrived at by the entire committee. A modified GRADE system was used to derive quality of evidence as 1 (high-quality evidence from consistent results of wellperformed randomised trials), 2 (moderate-quality evidence from randomised trials), 3 (low-quality evidence from observational studies, opinions gathered from respected authorities), or 4 (practice point). The strength of recommendations was categorised as either A (BRECOMMENDED^, strong recommendation) or B (BSUGGESTED^, weak recommendation) [3] .
Summary of Recommendations Clinical Evaluation and Diagnosis
Patient history and physical examination are the essential components in the diagnosis of haemorrhoidal disease. Bleeding per rectum, prolapse (something coming out per rectum), perianal swelling, and itching are the common symptoms of haemorrhoids. Pain occurs in cases with complicated haemorrhoids. Symptoms like feeling of incomplete evacuation, change in bowel habits, and weight loss need to be further evaluated to rule out other pathologies such as anal and rectal carcinomas, anal condylomata, and inflammatory bowel disease. A diagnosis is made using proctoscopy and sigmoidoscopy. Further, a full colonoscopy is recommended in selected patients with suspicious symptoms as above and in those with rectal bleeding, occult gastrointestinal bleeding, iron-deficiency anaemia, positive faecal occult blood test, and age ≥50 years and not having a complete colon examination within the past 10 years. (Grade A, Evidence Level 3) [2, [4] [5] [6] [7] The consensus committee also proposed a new classification of haemorrhoids as presented in Table 1 .
Management of Haemorrhoids
See Fig. 1 for a general approach for the management of haemorrhoids.
Dietary and Lifestyle Modifications
Haemorrhoidal patients should be recommended to follow a dietary modification involving increased fibre intake with adequate fluid as a first-line treatment. (Grade A, Evidence Level 2) [8, 9] If constipation is a predominant factor, it should be treated carefully using laxatives like polyethylene glycol, lactulose, and bulking agents. (Grade A, Evidence Level 4)
Medical Management
Medical management by micronised purified flavonoid fraction (MPFF) is recommended as a first-line treatment for grade I-II (a-c) and selected/minor grade III (a-c) haemorrhoids. Acutely bleeding haemorrhoids can be effectively treated by MPFF. In an acute haemorrhoidal attack, MPFF 1000 mg can be prescribed at a dose of three tablets daily for 4 days followed by two tablets daily for 3 days. Further, a maintenance dose of MPFF 1000 mg is preferred once daily for a minimum period of 2 months or more at physician's discretion. (Grade A, Evidence Level 1) [10, 11] MPFF also serves as an effective adjuvant to surgery and other procedures. Other existing veno-active drugs like calcium dobesilate, heparan sulphate, Euphorbia prostrata, and Ginkgo biloba have a low level of evidence in the management of haemorrhoids. Calcium dobesilate has been associated with an increased risk of agranulocytosis. (Grade B, Evidence Level 3) [12] [13] [14] [15] [16] [17] The long-term use of topical products, particularly, preparations containing steroid should be avoided due to their detrimental effects. (Grade B, Evidence Level 4)
Non-surgical Office Procedures
Rubber band ligation, injection sclerotherapy, and infrared coagulation can all be used in the treatment of grade I-II and selective grade III haemorrhoids. The success rates are highest with rubber band ligation albeit with a higher complication rate. (Grade A, Evidence Level 2) [18, 19] 
Surgical Management of Haemorrhoids
Haemorrhoidectomy Haemorrhoidectomy is a suitable option for the treatment of grade III-IV haemorrhoids; however, it may be associated with postoperative complications. The closed procedure has more advantages in terms of postoperative pain and bleeding than an open procedure. Advanced techniques like ligasure, harmonic scalpel, and mono-or bipolar modes of electrosurgery could be helpful in overcoming some of the disadvantages of conventional haemorrhoidectomy. (Grade A, Evidence Level 2) [20] [21] [22] Stapled Haemorrhoidopexy Stapled haemorrhoidopexy is recommended in the treatment of grade III-IV (a-c) haemorrhoids. Stapled haemorrhoidopexy compared to conventional haemorrhoidectomy is more effective in pain control 
